Overview of electrocardiographic and cardiovascular safety data for sparfloxacin

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. A, 1996, Pages 161-167

  Jaillon, P ^a,e   Morganroth, J ^b   Brumpt, I ^c   Talbot, G ^d  

^a S Antoine University Medical Centre   (France)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Rhone DPC   (France)

^d SANOFI   (France)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SPARFLOXACIN;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN EXPERIMENT; KIDNEY FAILURE; LIVER FAILURE; MALE; META ANALYSIS; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SINUS TACHYCARDIA; SYNCOPE;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CARDIOVASCULAR SYSTEM; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE III; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; QUINOLONES; RANDOMIZED CONTROLLED TRIALS;

EID: 0029951373     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.161     Document Type: Article

References (4)

1. Hondeghem, L. M. & Snyders. (1990). Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation 81, 686-90.
2. Lepeschkin, E. & Surawicz, B. (1952). The measurement of the Q-T interval of the electrocardiogram. Circulation, 4, 378-8.
3. Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R. & Levy, D. (1992). An improved method for adjusting the QT interval for heart rate. American Journal of Cardiology 70, 797-801.
4. Thomas, S. H. L. (1994). Drugs, QT interval abnormalities and ventricular arrhythmias. Adverse Drug Reactions and Toxicological Reviews 13, 77-102.